Service platform for in situ sequencing-based cell type mapping
| Reference number | |
| Coordinator | CartaNA AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | November 2017 - April 2018 |
| Status | Completed |
| Venture | Innovative Startups |
Important results from the project
The goal of this project was to validate our in situ sequencing service business model and analyze our target customer segment in more depth. For that purpose we executed two parts during this project: - Technical validations of the prototype reagent kits and service business model together with 5 pilot customers. - Market, customer need and competitor analysis.
Expected long term effects
In this project we generated: - technical validation of the prototype reagent kits and the service business model together with 5 pilot customers. We successfully performed and concluded 4/5 pilot customer projects that resulted in valuable research data. 1 project had technical difficulties, from which we learned an important technical aspect that we now can manage. - a detailed market analysis report that includes a list of potential academic and industrial customers (institutes and companies) and the competitor landscape.
Approach and implementation
The ISS reagent kits were handed/shipped to our pilot customers that performed the sample preparation step in their own laboratory with instructions. We then received samples for ISS service, which we performed in our CARTANA facilities and using a microscope that we rented from Stockholm University. The market analysis has been based on four data sources: bibliometric analysis (Scopus), clinical trials, LinkedIn and other web data. Customer needs have been validated by interviews. Marketing material (designs, web content, etc.) has been generated with help of consultants.